Invention Grant
- Patent Title: Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
-
Application No.: US15497446Application Date: 2017-04-26
-
Publication No.: US09771350B2Publication Date: 2017-09-26
- Inventor: Adam D. Hughes , Daniel Byun , Yan Chen , Melissa Fleury , John R. Jacobsen , Eric L. Stangeland , Richard D. Wilson , Rose Yen
- Applicant: Theravance Respiratory Company, LLC
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Respiratory Company, LLC
- Current Assignee: Theravance Respiratory Company, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Robert J. Smith
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/4709 ; A61K45/06
Abstract:
This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.
Public/Granted literature
- US20170226082A1 Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity Public/Granted day:2017-08-10
Information query
